Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

AMC Entertainment Stock Could Head 20% to 50% Higher From Here

By Mark R. Hake, CFA

AMC Entertainment stock looks undervalued after earnings. According to my models, AMC stock is worth 20% to 50% more than its current price.

KemPharm Stock Is Having a Hard Time After Its Recent Runup

By Mark R. Hake, CFA

KemPharm has a new ADHD drug, but after a recent short-squeeze KMPH stock is likely to fall without further financing.

Zomedica’s Pet Lab Product Launch Will Push Its Value Higher

By Mark R. Hake, CFA

Zomedica’s product launch will push its value higher. ZOM stock is worth between $2.45 to $3.17 with a 10% share of the pet diagnostic lab market.

Denison Mines Is a Uranium Mining Stock That Requires Too Much Care

By Mark R. Hake, CFA

Denison Mines is a penny uranium mining stock. DNN stock is worth 25% to 35% less than today's price as its project discount rate is too low.

Castor Maritime Poised to Trade Lower Toward Its Inherent Book Value

By Mark R. Hake, CFA

Castor Maritime is set to trade lower toward its inherent book value. CTRM stock has an indeterminate book value per share (BVPS), but it is likely to fall at least 50% from here.

Uber Stock Faces a Valuation Dilemma If Its Labor Costs Rise

By Mark R. Hake, CFA

Uber Technologies stock faces valuation dilemma if its labor costs rise. UBER stock could take a huge hit if it is required to guarantee wages and provide benefits.

7 Stocks for Value Investors to Buy Near Their 52-Week Lows

By Mark R. Hake, CFA

Sometimes a selloff is a sign of more pain to come, but these are 7 stocks to buy if you think a rebound may be close at hand.

Koss Corp Still Has Not Raised Capital at Its Elevated Stock Price

By Mark R. Hake, CFA

Koss Corp still has not raised capital at its elevated stock price. Koss stock would benefit from equity, convertible debt and/or preferred capital raise.

Don’t Expect Penn National Gaming Stock to Spike Like Last Year

By Mark R. Hake, CFA

Don't expect Penn National Gaming stock to spike as it did last year. PENN stock is close to its fair value, although It might have one more last call.

Pfizer Stock Is a Good Value Given Its Valuation History

By Mark R. Hake, CFA

Pfizer stock is good value here given its valuation history. PFE stock is worth at least 18% more based on its historical yield and forward P/E ratio.

Load More